Bizengri Injection
Product Images NDC 83077-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bizengri (NDC 83077-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merus Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Biz01 0001 01)

FDA Label Image

Figure (Biz01 0001 02)

FDA Label Image

Principal Display Panel – 750 mg Carton Label (Biz01 0001 03)

Principal Display Panel – 750 mg Carton Label (Biz01 0001 03)
This is a detailed description of a pharmaceutical product called Bizengri. It contains 375 mg per 18.75 mL of zenocutuzumab-zbeo along with other ingredients such as histidine, L-histidine hydrochloride monohydrate, polysorbate 20, rahalose, and water for injection. The dosage and storage instructions are provided, emphasizing the need to store it refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton. The product is for intravenous infusion use and each carton consists of a single-dose vial. It is advised not to freeze or shake the vial. The text also mentions barcodes containing product information like GTIN, SIN, and Lot numbers, aiding in tracking and identification.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.